NEUP

3.59

4.36% 0.15

Handel nachbörslich: 3.65 0.06 +1.67%

Neuphoria Therapeutics Inc (NEUP)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

$3.44

Offen:

$3.32

24-Stunden-Volumen:

98,313

Relative Volume:

1.49

Marktkapitalisierung:

$19.40M

Einnahmen:

$15.00M

Nettoeinkommen (Verlust:

$2.71M

KGV:

2.8212

EPS:

1.2725

Netto-Cashflow:

$-2.89M

1W Leistung:

-17.85%

1M Leistung:

-20.04%

6M Leistung:

-9.57%

1J Leistung:

-49.86%

1-Tages-Spanne:

$3.32

$3.7469

1-Wochen-Bereich:

$3.19

$4.6433

52-Wochen-Spanne:

$3.19

$21.40

Neuphoria Therapeutics Inc Stock (NEUP) Company Profile

Firmenname

Neuphoria Therapeutics Inc

Sektor

Healthcare (1094)

Branche

Biotechnology (615)

Telefon

781-439-5551

Adresse

100 SUMMIT DR, BURLINGTON

Mitarbeiter

Twitter

Nächster Verdiensttermin

2026-05-19

Neueste SEC-Einreichungen

NEUP's Discussions on Twitter

Compare NEUP vs VRTX, REGN, ARGX, ALNY, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
NEUP Neuphoria Therapeutics Inc	3.59	18.59M	15.00M	2.71M	-2.89M	1.2725
VRTX Vertex Pharmaceuticals Inc	522.25	134.41B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	676.23	68.13B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	919.94	57.01B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	321.59	41.79B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	190.46	40.39B	742.00K	-1.37B	-1.07B	-7.0731

Neuphoria Therapeutics Inc Stock (NEUP) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-09-28	Hochstufung	H.C. Wainwright	Neutral → Buy
2023-09-28	Bestätigt	Maxim Group	Buy
2022-01-10	Eingeleitet	Berenberg	Buy
2022-01-10	Eingeleitet	Cantor Fitzgerald	Overweight
2022-01-10	Eingeleitet	Evercore ISI	Outperform
2022-01-10	Eingeleitet	H.C. Wainwright	Buy

Alle ansehen

Neuphoria Therapeutics Inc Aktie (NEUP) Neueste Nachrichten

Jul 03, 2026

NEUPNeuphoria Therapeutics Inc Latest SEC Filings - Finviz

Jul 03, 2026

Jul 01, 2026

MRK, NEUP stocks drop as Merck scraps another Alzheimer’s drug trial under Neuphoria partnership - MSN

Jul 01, 2026

MRK, NEUP Stocks Drop As Merck Scraps Another Alzheimer’s Drug Trial Under Neuphoria Partnership - Asianet Newsable

Jul 01, 2026

MRK, NEUP Stocks Drop As Merck Scraps Another Alzheimer's Drug Trial Under Neuphoria Partnership - Menafn

Jul 01, 2026

Jun 26, 2026

Scancell Confirms Advanced Talks for Potential Acquisition of Nasdaq-listed Neuphoria Therapeutics - Moomoo

Jun 26, 2026

Neuphoria confirms merger talks with Scancell Holdings - Investing.com UK

Jun 26, 2026

Neuphoria confirms merger talks with Scancell Holdings By Investing.com - Investing.com Nigeria

Jun 26, 2026

Neuphoria Therapeutics (NEUP) Confirms Acquisition Talks with Sc - GuruFocus

Jun 26, 2026

Neuphoria Therapeutics Inc's stock price recorded a significant increase of 6% in after-hours trading, closing at $4.85. - Bitget

Jun 26, 2026

Neuphoria Therapeutics Confirms Discussions On Potential Acquisition By Scancell - TradingView

Jun 26, 2026

Neuphoria TherapeuticsConfirms Discussions - Moomoo

Jun 26, 2026

Neuphoria Responds to the announcement made by London-listed Scancell Holdings plc - GlobeNewswire

Jun 26, 2026

Neuphoria Therapeutics Inc. Actuals & Estimates (NASDAQ:NEUP) - TradingView

Jun 26, 2026

Scancell in talks for reverse merger with Neuphoria Therapeutics - Investing.com

Jun 26, 2026

Scancell confirms advanced talks over reverse merger with Neuphoria - Proactive financial news

Jun 26, 2026

Scancell confirms advanced talks on takeover of Neuphoria; eyes Nasdaq - marketscreener.com

Jun 26, 2026

Scancell in talks for reverse merger with Neuphoria Therapeutics By Investing.com - Investing.com Canada

Jun 26, 2026

NEUP Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026

Scancell confirms advanced reverse merger talks with US-listed Neuphoria - Share Talk

Jun 26, 2026

Jun 25, 2026

Scancell Confirms Advanced Talks over Reverse Merger with Neuphoria - marketscreener.com

Jun 25, 2026

Jun 24, 2026